MGNX
MacroGenics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.40
+3.53%Leverage
- Debt / equity
- 0.82x
- Net debt / equity
- -1.84x
- Debt / assets
- 0.10x
- Debt / EBITDA
- -0.43x
- Net debt / EBITDA
- 0.96x
Liquidity & coverage
- Current ratio
- 2.96x
- Quick ratio
- 2.96x
- Cash ratio
- 1.59x
- Interest coverage
- -2.41x
- EBITDA / interest
- -4.84x
- Working capital
- $212.9M
Cash & dividend
- FCF / debt
- -1.87x
- Cash flow / debt
- -1.82x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026